Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
RT @NCIDirector: Major issue regarding tobacco control in the time of e-cigarettes. https://t.co/91Pap0pnDu QT @SGottliebFDA: My op ed today in the @washingtonpost with @HHS Secretary Alex Azar @SecAzar - "We cannot let e-cigarettes become a… https://t.co/kRv2BBaNGm)
SteveFDA (R-D.C.)
@SGottliebFDA
RT @maloneyfiles: FDA commissioner @SGottliebFDA says e-cigarette use among middle schoolers has increased nearly 50% since last year… https://t.co/QaQIYwx498
SteveFDA (R-D.C.)
@SGottliebFDA
Biologics have become a crucial tool in treating many serious and life-threatening diseases, including cancer. But their costs may be prohibitively high for some patients. #FDA is taking new steps to facilitate more competition from biosimilars to drive competition and access
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA has reached out to partners in states impacted by the devastation from #HurricaneMichael with updated resources for farmers and food producers on crops harvested from flooded fields for food: https://t.co/EjRCHaB4gw and animal food: https://t.co/VIAF1a7EKZ
SteveFDA (R-D.C.)
@SGottliebFDA
My op ed today in the @washingtonpost with @HHS Secretary Alex Azar @SecAzar - "We cannot let e-cigarettes become an on-ramp for teenage addiction." https://t.co/fKviQsrY0W
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDATobacco: This October we are celebrating #HealthyLungMonth. Smoking can damage the lungs, which can turn the lung tissue a d… https://t.co/ZpWlWgxGdG
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDA_ORA: ATTN: Do you have problems navigating the agency? Do you need confidential information/advice on the regulatory pro… https://t.co/Ncv8QccM6a
SteveFDA (R-D.C.)
@SGottliebFDA
RT @PostOpinions: From @SecAzar and @SGottliebFDA: We cannot let e-cigarettes become an on-ramp for teenage addiction https://t.co/4ggaKhbtVG
SteveFDA (R-D.C.)
@SGottliebFDA
RT @ZacharyBrennan: FDA Sets Record Number of Generic Drug Approvals Again in FY 2018 https://t.co/w5LVlFmt8O
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDA_Drug_Info: New #FDA Update on Valsartan Recalls: FDA releases method for detection and quantification of both NDMA and NDEA: https://t.co/zXH2RinrMP.
SteveFDA (R-D.C.)
@SGottliebFDA
FDA has food safety information for retail and foodservice establishments resuming business in the aftermath of flooding or loss of power. Find everything you need here: https://t.co/Sv3gdZ04if https://t.co/xNuRFiNx0o
SteveFDA (R-D.C.)
@SGottliebFDA
RT @HHSGov: The @US_FDA has set a record for generic drug approvals in FY2018, breaking the record previously set in FY2017.… https://t.co/lkHwpb1zXT
SteveFDA (R-D.C.)
@SGottliebFDA
RT @jonathanrockoff: Percentage of young U.S. children who don’t receive any vaccines has quadrupled since 2001 https://t.co/9tHe7CMewn
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SecAzar: We're working closely with state health & local authorities to save lives and protect health after Hurricane… https://t.co/JkjPHDCESa
SteveFDA (R-D.C.)
@SGottliebFDA
The @US_FDA has set a new record for generic drug approvals in FY2018, breaking the record previously set in FY2017. https://t.co/bxRi7b3ebc https://t.co/efmEkf0HAL
SteveFDA (R-D.C.)
@SGottliebFDA
RT @PostOpinions: We cannot let e-cigarettes become an on-ramp for teenage addiction, @SecAzar and @SGottliebFDA write https://t.co/jiUMsInCex
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA will focus it’s generic policy development in 2019 on new proposals to advance more high value opportunities for generic drug manufacturers, including complex drugs, and steps to improve overall efficiency, and lower the cost, of generic development https://t.co/LKNBD24ZKH
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: In a new op-ed, I join @SecAzar to voice our concern about the epidemic of youth e-cigarette use, the current steps… https://t.co/xa7Nxfh2KQ
SteveFDA (R-D.C.)
@SGottliebFDA
Our cardiac device safety communication for certain Medtronic products provides helpful information for providers who program these cardiac devices, as well as info for patients. Read more: https://t.co/MB1jr0lIwn
SteveFDA (R-D.C.)
@SGottliebFDA
If e-cigarette products are being unlawfully marketed, outside the #FDA's compliance policy, the agency will act to remove them. https://t.co/EAArCkiZth